Team - ViRelieve

OUR MANAGEMENT TEAM

CEO MESSAGE TO INVESTORS

We are uniquely poised to succeed in our venture to deliver efficient drug candidates to clinical trials in a timely and cost-effective manner.

IVAN IVANOV

Ivan Ivanov, PhD President & CEO
Craig Shimasaki, PhD, MBA Business Development Director
Origene Nyanguile, PhD Vice-president of Pre-clinical development

IP and corporate consultants:

Alexandra Carrel, Esq Corporate counsel

Have questions? Contact our manager for details.

SEND NOW!

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.